SHISEIDO IBUKI MULTI SOLUTION

GEL

Drug Facts

Active ingredient

SALICYLIC ACID 0.5%

Purpose

Acne treatment

Use

for the treatment of acne

Warnings

For external use only

When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

clean the skin thoroughly before applying this product.
cover the entire affected area with a thin layer one to three times daily
because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Inactive ingredients

WATER•BUTYLENE GLYCOL•SD ALCOHOL 40-B•DIMETHICONE•PEG/PPG-14/7 DIMETHYL ETHER•PEG-240/HDI COPOLYMER BIS-DECYLTETRADECETH-20 ETHER•GLYCYL GLYCINE•PEG-60 HYDROGENATED CASTOR OIL•SILICA•TREHALOSE•SODIUM CHLORIDE•GELLAN GUM•DIPOTASSIUM GLYCYRRHIZATE•SERINE•POLYQUATERNIUM-51•PAEONIA SUFFRUTICOSA ROOT EXTRACT•AESCULUS HIPPOCASTANUM (HORSE CHESTNUT) SEED EXTRACT•HYDROGENATED LECITHIN•POTASSIUM HYDROXIDE•DISODIUM EDTA•SODIUM CITRATE•ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER•ALCOHOL•CITRIC ACID•GLYCERIN•BHT•PEG-30 SOY STEROL•TRISODIUM EDTA•PHENOXYETHANOL•FRAGRANCE•YELLOW 5•BLUE 1•

Other information

protect this product in this container from excessive heat and direct sun.

Questions or comments?

Call toll free 1-800-906-7503

PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton

SHISEIDO

Total Skin Rescue

IBUKI

Multi Solution Gel

roughness + visible pore care
+ salicylic acid acne treatment

30mL NET WT. 1 OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Jar Carton

SHISEIDO IBUKI MULTI
salicylic acid gel

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:58411-340
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	154 mg in 30 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
DIMETHICONE (UNII: 92RU3N3Y1O)
PEG/PPG-14/7 DIMETHYL ETHER (UNII: 6DNW9T7YT2)
DIGLYCINE (UNII: 10525P22U0)
PEG-60 HYDROGENATED CASTOR OIL (UNII: 02NG325BQG)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TREHALOSE (UNII: B8WCK70T7I)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
GELLAN GUM (LOW ACYL) (UNII: 7593U09I4D)
GLYCYRRHIZINATE DIPOTASSIUM (UNII: CA2Y0FE3FX)
SERINE (UNII: 452VLY9402)
PAEONIA X SUFFRUTICOSA ROOT (UNII: 7M7E9A2C8J)
HORSE CHESTNUT (UNII: 3C18L6RJAZ)
POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
EDETATE DISODIUM (UNII: 7FLD91C86K)
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)
ALCOHOL (UNII: 3K9958V90M)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
GLYCERIN (UNII: PDC6A3C0OX)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
EDETATE TRISODIUM (UNII: 420IP921MB)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
FD&C YELLOW NO. 5 (UNII: I753WB2F1M)
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:58411-340-50	1 in 1 CARTON	02/01/2015	07/31/2018
1		30 mL in 1 JAR; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph drug	M006	02/01/2015	07/31/2018

Labeler - SHISEIDO AMERICAS CORPORATION (193691821)

Name	Address	ID/FEI	Business Operations
Establishment
SHISEIDO AMERICA INC.		782677132	manufacture(58411-340) , analysis(58411-340)

Revised: 12/2023

Document Id: d30c8873-5744-429b-bc8c-4d126a98aa3a

Set id: f354b318-b849-47df-8a34-0c75344b7006

Version: 4

Effective Time: 20231229

SHISEIDO AMERICAS CORPORATION

SHISEIDO IBUKI MULTI SOLUTION GEL